Positive Symptom Control

Positive Symptom Control is a therapeutic outcome construct in schizophrenia pharmacotherapy that refers to the reduction or attenuation of psychotic manifestations such as hallucinations, delusions, and disorganized thinking, distinguishing it from interventions targeting negative or cognitive symptoms.

79

Publications

4.5K

Citations

345

Authors

193

Institutions

Publications per year

2017–2026

9

Authors

345

  1. LY
    Lawrence Yusupoff

    University of Manchester, United Kingdom

    2 publications · 27 citations

    2

    h-index

  2. DT
    Douglas Turkington

    Newcastle University, United Kingdom

    2 publications · 711 citations

    2

    h-index

  3. TR
    Thomas R. E. Barnes

    Imperial College London, United Kingdom

    2 publications · 800 citations

    2

    h-index

  4. JE
    John Ellershaw

    Marie Curie Palliative Care Institute Liverpool, United Kingdom

    2 publications · 621 citations

    2

    h-index

  5. RS
    Ronald Siddle

    University of Manchester, United Kingdom

    2 publications · 711 citations

    2

    h-index

1–5 of 345

Venues

  1. The Journal of Nervous and Mental Disease

    7 publications · 153 citations

    7

    h-index

  2. Psychiatry Research

    6 publications · 186 citations

    6

    h-index

  3. PubMed

    Repository · 5 publications · 162 citations

    5

    h-index

  4. The British Journal of Psychiatry

    BJP · 4 publications · 190 citations

    4

    h-index

  5. Schizophrenia Research

    4 publications · 141 citations

    4

    h-index

1–5